Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Impact of Baseline Features and Risk Factor Control on Cognitive Function in the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial.

Turan TN, Al Kasab S, Smock A, Cotsonis G, Bachman D, Lynn MJ, Nizam A, Derdeyn CP, Fiorella D, Janis S, Lane B, Montgomery J, Chimowitz MI; MBChB for the SAMMPRIS Investigators.

Cerebrovasc Dis. 2019;47(1-2):24-31. doi: 10.1159/000497245. Epub 2019 Feb 14.

2.

Type and Duration of Exercise in the SAMMPRIS Trial.

Turan TN, Kasab SA, Nizam A, Hannah J, Gordon N, Lynn MJ, Derdeyn CP, Fiorella D, Janis LS, Lane BF, Montgomery J, Chimowitz MI; SAMMPRIS Investigators.

Neurologist. 2019 Jan;24(1):10-12. doi: 10.1097/NRL.0000000000000211.

PMID:
30586027
3.

Hemodynamic Markers in the Anterior Circulation as Predictors of Recurrent Stroke in Patients With Intracranial Stenosis.

Wabnitz AM, Derdeyn CP, Fiorella DJ, Lynn MJ, Cotsonis GA, Liebeskind DS, Waters MF, Lutsep H, López-Cancio E, Turan TN, Montgomery J, Janis LS, Lane B, Chimowitz MI; SAMMPRIS Investigators.

Stroke. 2018 Dec 11:STROKEAHA118020840. doi: 10.1161/STROKEAHA.118.020840. [Epub ahead of print]

PMID:
30580705
4.

Treatment effect on ordinal functional outcome using piecewise multistate Markov model with unobservable baseline: an application to the modified Rankin scale.

Cassarly C, Martin RH, Chimowitz M, Peña EA, Ramakrishnan V, Palesch YY.

J Biopharm Stat. 2019;29(1):82-97. doi: 10.1080/10543406.2018.1489404. Epub 2018 Jul 9.

PMID:
29985739
5.

Assessing type I error and power of multistate Markov models for panel data-A simulation study.

Cassarly C, Martin RH, Chimowitz M, Peña EA, Ramakrishnan V, Palesch YY.

Commun Stat Simul Comput. 2017;46(9):7040-7061. doi: 10.1080/03610918.2016.1222425. Epub 2016 Sep 23.

6.

Relationship between Risk Factor Control and Compliance with a Lifestyle Modification Program in the Stenting Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis Trial.

Turan TN, Al Kasab S, Nizam A, Lynn MJ, Harrell J, Derdeyn CP, Fiorella D, Janis LS, Lane BF, Montgomery J, Chimowitz MI; SAMMPRIS Investigators.

J Stroke Cerebrovasc Dis. 2018 Mar;27(3):801-805. doi: 10.1016/j.jstrokecerebrovasdis.2017.10.017. Epub 2017 Nov 21.

PMID:
29169967
7.

Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia.

Nagahama Y, Allan L, Nakagawa D, Zanaty M, Starke RM, Chalouhi N, Jabbour P, Brown RD, Derdeyn CP, Leira EC, Broderick J, Chimowitz M, Torner JC, Hasan D.

J Neurosurg. 2018 Sep;129(3):702-710. doi: 10.3171/2017.5.JNS17831. Epub 2017 Nov 3.

PMID:
29099296
8.

Effects of Spaceflight on Astronaut Brain Structure as Indicated on MRI.

Roberts DR, Albrecht MH, Collins HR, Asemani D, Chatterjee AR, Spampinato MV, Zhu X, Chimowitz MI, Antonucci MU.

N Engl J Med. 2017 Nov 2;377(18):1746-1753. doi: 10.1056/NEJMoa1705129.

9.

Comparison of multistate Markov modeling with contemporary outcomes in a reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.

Cassarly C, Martin RH, Chimowitz M, Peña EA, Ramakrishnan V, Palesch YY.

PLoS One. 2017 Oct 26;12(10):e0187050. doi: 10.1371/journal.pone.0187050. eCollection 2017.

10.

Angioplasty, Stenting and Other Potential Treatments of Atherosclerotic Stenosis of the Intracranial Arteries: Past, Present and Future.

Wabnitz A, Chimowitz M.

J Stroke. 2017 Sep;19(3):271-276. doi: 10.5853/jos.2017.01837. Epub 2017 Sep 29. Review.

11.

Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials.

Howard VJ, Meschia JF, Lal BK, Turan TN, Roubin GS, Brown RD Jr, Voeks JH, Barrett KM, Demaerschalk BM, Huston J 3rd, Lazar RM, Moore WS, Wadley VG, Chaturvedi S, Moy CS, Chimowitz M, Howard G, Brott TG; CREST-2 study investigators.

Int J Stroke. 2017 Oct;12(7):770-778. doi: 10.1177/1747493017706238. Epub 2017 May 2.

12.

Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis).

Derdeyn CP, Fiorella D, Lynn MJ, Turan TN, Cotsonis GA, Lane BF, Montgomery J, Janis LS, Chimowitz MI; SAMMPRIS Investigators.

Stroke. 2017 Jun;48(6):1501-1506. doi: 10.1161/STROKEAHA.116.014537. Epub 2017 Apr 28.

PMID:
28455321
13.

Stroke Caused by Atherosclerosis of the Major Intracranial Arteries.

Banerjee C, Chimowitz MI.

Circ Res. 2017 Feb 3;120(3):502-513. doi: 10.1161/CIRCRESAHA.116.308441. Review.

14.

Postprandial Clearance of Oxidized Low-Density Lipoprotein in Patients with Stroke Due to Atherosclerosis.

Al Kasab S, Cassarly C, Le NA, Martin R, Brinley J, Chimowitz MI, Turan TN.

J Stroke Cerebrovasc Dis. 2017 Mar;26(3):488-493. doi: 10.1016/j.jstrokecerebrovasdis.2016.12.006. Epub 2017 Jan 6.

PMID:
28089094
15.

Relationship between risk factor control and vascular events in the SAMMPRIS trial.

Turan TN, Nizam A, Lynn MJ, Egan BM, Le NA, Lopes-Virella MF, Hermayer KL, Harrell J, Derdeyn CP, Fiorella D, Janis LS, Lane B, Montgomery J, Chimowitz MI.

Neurology. 2017 Jan 24;88(4):379-385. doi: 10.1212/WNL.0000000000003534. Epub 2016 Dec 21.

16.

Angioplasty and Stenting.

Leung TW, Wabnitz AM, Miao Z, Chimowitz MI.

Front Neurol Neurosci. 2016;40:152-163. Epub 2016 Dec 2. Review.

PMID:
27960179
17.

Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis?

Turan TN, Smock A, Cotsonis G, Bachman D, Al Kasab S, Lynn MJ, Nizham A, Derdeyn CP, Fiorella D, Janis S, Lane B, Montgomery J, Chimowitz MI; SAMMPRIS Investigators.

Cerebrovasc Dis. 2017;43(1-2):31-35. doi: 10.1159/000450964. Epub 2016 Nov 5.

18.

Impact of the New American Heart Association/American Stroke Association Definition of Stroke on the Results of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial.

Al Kasab S, Lynn MJ, Turan TN, Derdeyn CP, Fiorella D, Lane BF, Janis LS, Chimowitz MI; SAMMPRIS Investigators.

J Stroke Cerebrovasc Dis. 2017 Jan;26(1):108-115. doi: 10.1016/j.jstrokecerebrovasdis.2016.08.038. Epub 2016 Oct 17.

PMID:
27765556
19.

The urgent need for contemporary clinical trials in patients with asymptomatic carotid stenosis.

Chaturvedi S, Chimowitz M, Brown RD Jr, Lal BK, Meschia JF.

Neurology. 2016 Nov 22;87(21):2271-2278. Epub 2016 Sep 28. Review.

20.

Rationale for ischemic conditioning to prevent stroke in patients with intracranial arterial stenosis.

Al Kasab S, Hess DC, Chimowitz MI.

Brain Circ. 2016 Apr-Jun;2(2):67-71. doi: 10.4103/2394-8108.186260. Epub 2016 Jul 13. Review.

21.

Characterization of intracranial atherosclerotic stenosis using high-resolution MRI study--rationale and design.

Turan TN, LeMatty T, Martin R, Chimowitz MI, Rumboldt Z, Spampinato MV, Stalcup S, Adams RJ, Brown T.

Brain Behav. 2015 Sep 25;5(12):e00397. doi: 10.1002/brb3.397. eCollection 2015 Dec.

22.

Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial.

Waters MF, Hoh BL, Lynn MJ, Kwon HM, Turan TN, Derdeyn CP, Fiorella D, Khanna A, Sheehan TO, Lane BF, Janis S, Montgomery J, Chimowitz MI; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial Investigators.

JAMA Neurol. 2016 Mar;73(3):308-15. doi: 10.1001/jamaneurol.2015.4315. Erratum in: JAMA Neurol. 2016 Apr;73(4):481.

23.

Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial.

Kwon HM, Lynn MJ, Turan TN, Derdeyn CP, Fiorella D, Lane BF, Montgomery J, Janis LS, Rumboldt Z, Chimowitz MI; SAMMPRIS Investigators.

JAMA Neurol. 2016 Jan;73(1):36-42. doi: 10.1001/jamaneurol.2015.3145.

24.

Enrollment volume effect on risk factor control and outcomes in the SAMMPRIS trial.

Chiu D, Klucznik RP, Turan TN, Lynn MJ, McCane CD, Katz LB, Nizam A, Derdeyn CP, Fiorella D, Lane BF, Montgomery J, Janis S, Chimowitz MI.

Neurology. 2015 Dec 15;85(24):2090-7. doi: 10.1212/WNL.0000000000002191. Epub 2015 Nov 11.

25.

Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis?

Lutsep HL, Lynn MJ, Cotsonis GA, Derdeyn CP, Turan TN, Fiorella D, Janis LS, Lane BF, Montgomery J, Chimowitz MI; SAMMPRIS Investigators.

Stroke. 2015 Nov;46(11):3282-4. doi: 10.1161/STROKEAHA.115.009846. Epub 2015 Sep 17. Erratum in: Stroke. 2015 Nov;46(11):e248.

26.

Do Patient Characteristics Explain the Differences in Outcome Between Medically Treated Patients in SAMMPRIS and WASID?

Chaturvedi S, Turan TN, Lynn MJ, Derdeyn CP, Fiorella D, Janis LS, Chimowitz MI; SAMMPRIS Trial Investigators.

Stroke. 2015 Sep;46(9):2562-7. doi: 10.1161/STROKEAHA.115.009656. Epub 2015 Aug 6.

27.

Yet again no benefit of stenting over medical therapy.

Turan TN, Chimowitz MI.

Lancet Neurol. 2015 Jun;14(6):565-6. doi: 10.1016/S1474-4422(15)00049-6. Epub 2015 Apr 20. No abstract available.

PMID:
25908091
28.

Endovascular therapy for atherosclerotic intracranial arterial stenosis: back to the drawing board.

Chimowitz MI, Derdeyn CP.

JAMA. 2015 Mar 24-31;313(12):1219-20. doi: 10.1001/jama.2015.1276. No abstract available.

PMID:
25803345
29.

Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis.

Lutsep HL, Barnwell SL, Larsen DT, Lynn MJ, Hong M, Turan TN, Derdeyn CP, Fiorella D, Janis LS, Chimowitz MI; SAMMPRIS Investigators.

Stroke. 2015 Mar;46(3):775-9. doi: 10.1161/STROKEAHA.114.007752. Epub 2015 Jan 15.

30.

Racial/Ethnic differences in poststroke rehabilitation outcomes.

Ellis C, Hyacinth HI, Beckett J, Feng W, Chimowitz M, Ovbiagele B, Lackland D, Adams R.

Stroke Res Treat. 2014;2014:950746. doi: 10.1155/2014/950746. Epub 2014 Jun 15. Review.

31.

Infarct patterns, collaterals and likely causative mechanisms of stroke in symptomatic intracranial atherosclerosis.

López-Cancio E, Matheus MG, Romano JG, Liebeskind DS, Prabhakaran S, Turan TN, Cotsonis GA, Lynn MJ, Rumboldt Z, Chimowitz MI.

Cerebrovasc Dis. 2014;37(6):417-22. doi: 10.1159/000362922. Epub 2014 Jul 4.

32.

Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease.

Stroke. 2014 Jul;45(7):2160-236. doi: 10.1161/STR.0000000000000024. Epub 2014 May 1. Erratum in: Stroke. 2015 Feb;46(2):e54.

PMID:
24788967
33.

Game changer for endovascular treatment of acute ischemic stroke?

Chimowitz MI.

J Neurointerv Surg. 2014 May;6(4):252-3. doi: 10.1136/neurintsurg-2014-011187. Epub 2014 Mar 12. No abstract available.

PMID:
24623835
34.

Noninvasive fractional flow on MRA predicts stroke risk of intracranial stenosis.

Liebeskind DS, Kosinski AS, Lynn MJ, Scalzo F, Fong AK, Fariborz P, Chimowitz MI, Feldmann E.

J Neuroimaging. 2015 Jan-Feb;25(1):87-91. doi: 10.1111/jon.12101. Epub 2014 Mar 5.

35.

Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists.

Turan TN, Cotsonis G, Lynn MJ, Wooley RH, Swanson S, Williams JE, Stern BJ, Derdeyn CP, Fiorella D, Chimowitz MI.

Cerebrovasc Dis. 2014;37(3):203-11. doi: 10.1159/000358120. Epub 2014 Feb 19.

36.

Is calcification of intracranial arteries important and how?

Chimowitz MI, Caplan LR.

JAMA Neurol. 2014 Apr;71(4):401-2. doi: 10.1001/jamaneurol.2013.6224. No abstract available.

PMID:
24535614
37.

Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.

Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators.

Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3. Epub 2013 Oct 26.

38.

In reply: Is there a contribution of anesthesia to the outcome of the SAMMPRIS trial?

Derdeyn CP, Fiorella D, Chimowitz MI.

Neurosurgery. 2014 Feb;74(2):E235-6. doi: 10.1227/NEU.0000000000000227. No abstract available.

39.

Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment.

Holmstedt CA, Turan TN, Chimowitz MI.

Lancet Neurol. 2013 Nov;12(11):1106-14. doi: 10.1016/S1474-4422(13)70195-9. Review.

40.

The challenge of stroke prevention with intracranial arterial stenosis.

Turan TN, Smock A, Chimowitz MI.

Curr Cardiol Rep. 2013 Dec;15(12):422. doi: 10.1007/s11886-013-0422-y. Review.

41.

The Feinberg Award Lecture 2013: treatment of intracranial atherosclerosis: learning from the past and planning for the future.

Chimowitz MI.

Stroke. 2013 Sep;44(9):2664-9. doi: 10.1161/STROKEAHA.113.001290. Epub 2013 Jul 2. No abstract available.

42.

Intracranial stenting: SAMMPRIS.

Derdeyn CP, Fiorella D, Lynn MJ, Turan TN, Lane BF, Janis LS, Chimowitz MI.

Stroke. 2013 Jun;44(6 Suppl 1):S41-4. doi: 10.1161/STROKEAHA.111.000370. Review. No abstract available.

43.

MUSC's comprehensive stroke program: changing what's possible in stroke care across South Carolina.

Magarik JA, Jauch EC, Patel SJ, Adams RJ, Turner RD, Chaudry MI, Chalela JA, Hays A, Chimowitz MI, Turan TN, Holmstedt CA, Debenham E, Lackland DT, Turk AS.

J S C Med Assoc. 2012 Oct-Dec;108(5):128-31. Review. No abstract available.

44.

Endovascular treatment for acute ischemic stroke--still unproven.

Chimowitz MI.

N Engl J Med. 2013 Mar 7;368(10):952-5. doi: 10.1056/NEJMe1215730. Epub 2013 Feb 8. No abstract available.

PMID:
23394477
45.

Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial.

Derdeyn CP, Fiorella D, Lynn MJ, Rumboldt Z, Cloft HJ, Gibson D, Turan TN, Lane BF, Janis LS, Chimowitz MI; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators.

Neurosurgery. 2013 May;72(5):777-95; discussion 795. doi: 10.1227/NEU.0b013e318286fdc8.

46.

Response to critique of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial by Abou-Chebl and Steinmetz.

Chimowitz MI, Fiorella D, Derdeyn CP, Turan TN, Lane BF, Janis S, Lynn MJ.

Stroke. 2012 Oct;43(10):2806-9. No abstract available.

47.

Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.

Turan TN, Lynn MJ, Nizam A, Lane B, Egan BM, Le NA, Lopes-Virella MF, Hermayer KL, Benavente O, White CL, Brown WV, Caskey MF, Steiner MR, Vilardo N, Stufflebean A, Derdeyn CP, Fiorella D, Janis S, Chimowitz MI; SAMMPRIS Investigators.

Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):e51-60. No abstract available.

48.

Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS).

Fiorella D, Derdeyn CP, Lynn MJ, Barnwell SL, Hoh BL, Levy EI, Harrigan MR, Klucznik RP, McDougall CG, Pride GL Jr, Zaidat OO, Lutsep HL, Waters MF, Hourihane JM, Alexandrov AV, Chiu D, Clark JM, Johnson MD, Torbey MT, Rumboldt Z, Cloft HJ, Turan TN, Lane BF, Janis LS, Chimowitz MI; SAMMPRIS Trial Investigators.

Stroke. 2012 Oct;43(10):2682-8. Epub 2012 Sep 13.

49.

Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial.

Derdeyn CP, Fiorella D, Lynn MJ, Barnwell SL, Zaidat OO, Meyers PM, Gobin YP, Dion J, Lane BF, Turan TN, Janis LS, Chimowitz MI; SAMMPRIS Trial Investigators.

J Neurointerv Surg. 2013 Nov;5(6):528-33. doi: 10.1136/neurintsurg-2012-010504. Epub 2012 Sep 12.

50.

Response from the SAMMPRIS trial principal investigators regarding inaccuracies in this editorial.

Derdeyn CP, Fiorella D, Chimowitz M.

J Neurointerv Surg. 2016 Jun;8(e1):e5-6. doi: 10.1136/neurintsurg-2012-010496. Epub 2012 Sep 5. No abstract available.

PMID:
22952246

Supplemental Content

Loading ...
Support Center